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This study seeks to validate the conversion of PROMIS-GH scores to EQ-5D Health Utility Index (HUI) values.
Patients undergoing lumbar spine surgery were prospectively surveyed using EQ-5D-3L and PROMIS-GH short
form instruments. EQ-5D-HUI scores, and PROMIS scores converted to HUI were calculated. Neither instrument
demonstrated any floor effects. The EQ-5D-HUI demonstrated significantly higher ceiling effects. Patients re
ported a significantly higher mean HUI score using the EQ-5D compared to PROMIS-GH. Strong positive cor
relation and agreement were observed. Conversion of the PROMIS-GH to the EQ-5D-HUI appears to be viable for
evaluating the health status of patients undergoing lumbar spine surgery.

1. Introduction
As the expenditure on U.S. healthcare services continues to rise at a
projected growth rate of 5.5% annually,1 the value of medical and sur
gical interventions require increased scrutiny. Symptomatic spinal ste
nosis in the presence of lumbar degenerative spondylolisthesis (LDS) is a
relatively common condition affecting approximately 6–13% of the
population.2 The surgical management of spine pathologies presents a
significant cost to society, as demonstrated by the 2011 finding that
spinal fusion accounted for over $12 billion in annual cost to U.S. hos
pitals, the highest of any surgical procedure.3 The clinical effectiveness
of surgery for LDS is well established, as patients undergoing surgical
treatment have showed substantially greater improvement in pain and
function over periods of two, four and eight years than those treated
nonsurgically in a large prospective randomized controlled trial; how
ever, additional cost-effectiveness studies of this population are
needed.4–6 In order to assess the cost effectiveness and cost-utility of
treatment options across disease states with varying outcomes, stan
dardized measures of health status are required. The most commonly
used measure of health status in economic analysis is the quality
adjusted life year (QALY).7 The quantification of health status on a zero
to one-hundred point scale, herein described as a health utility index
(HUI), can be measured using a variety of generic patient reported
outcome measures (PROMs) to calculate QALYs.8

The Euroqol Five Dimensions of Health measured at three levels (EQ5D 3L) is a preference-based measure frequently used for calculation of
HUI scores given its ability to produce a single measure of health sta
tus.9,10 Considered the gold standard legacy measure of health status,
the EQ-5D has been validated in multiple patient populations across
differing geographies and disease states.11–14 Alternatively, the Patient
Reported Outcome Measurement Information System (PROMIS) Global
Health (GH) instrument is a standardized, generic patient-reported
measure of global health as measured by physical and mental health.15
Given its strong psychometric performance, ability to be integrated
into electronic health record systems, and flexibility in application, the
use of PROMIS instruments has rapidly increased.16 Despite this uptake,
a limitation of the PROMIS GH instrument is its inability to produce a
HUI value for use in the calculation of QALYs for cost effectiveness
analysis. To fill this gap, a variety of methodologies for calculating HUI
values from PROMIS GH scores have been proposed,17–19 although none
have been validated specifically for patients undergoing surgery for LDS.
This study seeks to validate the conversion of the PROMIS GH scores to
HUI values using a previously published methodology. If successful, this
would enhance the utility of the PROMIS GH instrument for economic
analysis of surgery for LDS and could potentially reduce the requirement
for using multiple generic health status PROMs in spine clinics, thus
reducing patient burden and enhancing efficiency.
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2. Methods

statistical analysis was performed using SPSS version 26 (IBM, Armonk,
NY).

Seventy patients undergoing surgery for LDS by two fellowship
trained orthopedic spine surgeons at a regional medical center from
April 2017 to December 2018 were prospectively surveyed after
receiving institutional review board approval. All patients were over
eighteen years old and underwent primary surgery for LDS; revisions
and patients with congenital or isthmic spondylolisthesis were excluded.
After providing consent, patients were mailed a paper survey consisting
of the EQ-5D 3L and the PROMIS Global Health v1.2 Short Form. All
patients were mailed a first survey no earlier than nine months post
operatively and no later than fifteen months postoperatively. If no
response was received within sixty days, a second survey was sent. Pa
tient surveys were paired with demographics and information about
their surgery and entered into a secure database. Health index values
were calculated from the EQ-5D 3L using the US based time trade off
weightings.10 PROMIS physical and mental health component scores
were calculated and converted to EQ-5D 3L index values using the
methodology described by Revicki et al.17 Descriptive statistics were
run, and various techniques including paired and independent sample
T-tests, Wilcoxon Signed Rank test, Pearson product moment correla
tion, Bland Altman analysis, Cronbach’s Alpha, and intraclass correla
tion were employed to assess instrument coverage, validity, and
reliability. Statistical significance was assess at the α = 0.05 level. All

3. Results
3.1. Descriptive statistics
Thirty-three (47%) of patients responded to the survey with an
average response time of 355 ± 77 days. The mean EQ-5D HUI for the
population was 0.856 with a standard deviation of 0.131, compared to a
PROMIS GH HUI of 0.732 with a standard deviation of 0.105. Median
EQ-5D HUI was 0.827 compared to 0.768 for PROMIS GH HUI. Both
measurements resulted in negative skew, with EQ-5D demonstrating a
slight level (− 0.352) and PROMIS GH demonstrating a moderate level
(− 0.726). Negative kurtosis was observed for both distributions (EQ-5D
HUI = − 1.006, PROMIS GH HUI = − 0.276) suggesting a platykurtic
distribution of scores.20 Normality of the distributions was assessed
using Kolmogorov-Smirnov and Shapiro-Wilk tests, histograms and Q-Q
plots. Neither the EQ-5D HUI (KS = 0.273, p < .001); SW = 0.841, p <
.001) nor PROMIS GH HUI (KS = 0.188, p = .004; SW = 0.932, p = .041)
were normally distributed, although Q-Q plot alignment demonstrated
relatively close alignment to the normal distribution (Fig. 1). A summary
of descriptive statistics is presented in Table 1 and a histogram of the
distributions is presented in Fig. 2.

Fig. 1. Normal Q-Q plots depicting the EQ-5D HUI and PROMIS GH HUI values.
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3.2. Instrument coverage

Table 1
Health utility index distribution descriptive statistics.
Mean
95% CI
Median
Variance
Standard Deviation
Coefficient of Variation
Minimum
Maximum
Range
Interquartile Range
Skewness
Kurtosis
Normality: Kolmogorov-Smirnov
Normality: Shapiro-Wilk

EQ-5D HUI

PROMIS GH HUI

.865
.818–.911
.827
.017
.131
6.60
.597
1.000
.403
.222
-.352
− 1.006
.273 (p < .001)
.841 (p < .001)

.732
.695–.770
.768
.011
.105
6.97
.472
.877
.405
.177
-.726
-.276
.188 (p = .004)
.932 (p = .041)

Coverage was defined as the continuum of a specific trait that can be
assessed reliably by an instrument21 and assessed by evaluation of the
floor and ceiling effects of the two methodologies evaluated. Neither the
EQ-5D HUI nor PROMIS GH HUI demonstrated any floor effect in this
sample. The EQ-5D HUI demonstrated significantly higher ceiling ef
fects, with 14 of 33 (42.4%) patients reporting a perfect health state of
1.0; no patients achieved a health status of 1.0 using the PROMIS HUI
conversion methodology, but 1 (3.0%) reached the maximum possible
converted HUI value of 0.877. Graphical depiction of this ceiling can be
observed in Fig. 2 histograms and Fig. 3 boxplots.
3.3. Validity assessment
Convergent construct validity was assessed using multiple methods.

Fig. 2. Histograms of the HUI score distributions for the EQ-5D HUI and PROMIS GH HUI.
69

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on March 08, 2021.
For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

J. Turcotte et al.

Journal of Orthopaedics 23 (2021) 67–72

Fig. 3. Boxplot of the HUI score distributions for the EQ-5D HUI and PROMIS GH HUI.

Paired sample T-Tests indicated patients reported a significantly higher
mean HUI score using the EQ-5D instrument than PROMIS GH (avg. =
0.865 vs. 0.732, t = 9.050, p < .001). This was confirmed by one sample
T-Test of the mean difference between scores (avg. = 0.132 ± 0 .084, t =
9.050, p < .001). Given deviation from the normal distribution and
small sample size, median differences were also assessed using the
related-samples Wilcoxon Signed rank test. A significant difference in
median scores using the two methods was found (standardized test
statistic = 4.851, p < .001). Pearson product moment correlation was
performed to assess the linear relationship between HUI scores. The
correlation coefficient (r) was .73 (p < .001) showing a strong posi
tive,22 significant correlation between HUI scores using the two meth
odologies. Agreement between measures was then assessed using Bland
Altman analysis.23,24 The difference in HUI score using the alternative
methodologies was plotted against the mean of the two measures and
assessed against a 95% confidence interval around the mean (Fig. 4).
One of 33 data points fell outside of the 95% agreement interval, sug
gesting strong agreement between the instruments. Linear regression
was then conducted to assess the relationship between mean HUI score
of the two instruments and difference in calculated HUI scores. No

significant relationship was found (β = .247, t = 1.922, p = .064),
indicating no proportional bias between instruments.
3.4. Reliability assessment
Internal consistency of responses to each instrument was assessed
using Cronbach’s alpha. The EQ-5D had a Cronbach’s alpha of 0.821,
demonstrating good internal consistency.25 Cronbach’s alpha assess
ment comparing the physical and mental health components of the
PROMIS GH instrument resulted in a score of 0.890, also suggesting
good internal consistency. Reliability of the HUI scores between in
struments was then assessed. Cronbach’s alpha was 0.857. Intraclass
correlation was conducted to evaluate the level of agreement between
the two instruments. An intraclass correlation coefficient of 0.857 (p <
.001) revealed strong positive agreement between instruments.
4. Discussion
Our study demonstrates that conversion of the PROMIS GH to EQ-5D
HUI is a valid and reliable method quantifying health status in patients

Fig. 4. Bland Altman depiction of agreement between the EQ-5D HUI and PROMIS GH HUI scores.
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undergoing surgery for LDS. Specifically, conversion of the PROMIS GH
to EQ-5D resulted in reduced ceiling effects, while displaying adequate
convergent construct validity, agreement, and internal consistency
when compared to the EQ-5D HUI score. However, the significantly
lower absolute HUI scores produced by the conversion formula must be
recognized, and comparisons between studies using the alternative
methodologies must consider the impact of the relatively lower health
index values.
Both the EQ-5D and PROMIS instruments have been validated in low
back pain and spine surgery patient populations.21,26,27 In a prospective
study of 325 patients undergoing low back surgery, Solberg et al. eval
uated the psychometric properties of the EQ-5D compared to the legacy
Oswestry Disability Index (ODI)—the most commonly cited disease
specific measure of health status for low back conditions28—and
concluded the instrument displayed strong validity, reliability and
responsiveness, and is suitable for use in cost utility analysis of this
population.26 The two components of the PROMIS GH, physical function
and mental health, have been independently validated in orthopedic and
spine patients. In comparison with the ODI, the PROMIS physical
function scale has been found to have better coverage, as denoted by
reduced floor effects compared to the ODI.21,29 Validity of the PROMIS
physical function scale in patients with spinal conditions was concluded
based on strong correlation with the ODI r = − 0.81 in a study of 1607
patients with back and leg pain in a spine clinic.27 The mental health
component of the PROMIS GH instrument demonstrates high reliability,
as measured by an internal consistency coefficient of 0.86. The mea
sure’s validity has been established through correlation with
disease-specific PROMIS measurements; the mental health component
of the GH instrument correlates strongly with the PROMIS depression
scale (r = − 0.71).30 Construct validity has been established across
various disease states through significant positive correlation with other
disease-specific and generic measures of mental health.31,32 In a
cross-sectional study of 14,962 orthopedic patients using the PROMIS
anxiety, depression, physical function and pain interference scale,
Beleckas et al. concluded that 20% of new orthopedic patients exhibit
anxiety levels that may require intervention, with an even higher rate of
32.4% apparent in spine patients. The study further concluded that
PROMIS physical function scores correlate more strongly with PROMIS
anxiety scores than depression scores, suggesting the utility of assessing
this specific dimension of mental health in orthopedic patients.33
The methodology for converting PROMIS GH to EQ-5D HUI values
used in our study was established by Revicki et al., in 2009.17 Using a
sample of 20,400 cases from the PROMIS Wave 1 population, the au
thors employed a series of linear regression models to derive the final
linear equation for conversion that is presented in the official PROMIS
GH v1.2 scoring manual.15 Using various items from the PROMIS GH
instrument, 65% of the variance in EQ-5D HUI scores was explained,
compared to 57% of the variance when using the PROMIS GH summary
or domain scores. This result was comparable to other conversions to
EQ-5D index scores; Lawrence and Fleishman explained 61–63% of
EQ-5D index variance using the SF-12 summary score, while other
methodologies using a variety of instruments explained 58–63% of the
index values.17,34–36 Differences between the predicted and actual index
scores were between 0 and 0.02 points by gender and age groups, and an
intraclass correlation coefficient of 0.77 between the actual and pre
dicted scores indicated good agreement.17 Despite its inclusion in the
PROMIS scoring guide, this conversion method has been critiqued for
limitations including its underestimation of high HUI values and over
estimation of low values as the equation only yields scores ranging from
0.328 to 0.877, thus resulting in artificial regression to the mean.18
Alternative methods of converting PROMIS scores to HUI values for
economic analysis have been presented. In 2014, Craig et al. presented a
method of converting PROMIS-29 responses directly into QALYs for
cost-effectiveness research.19 Using a sample of 7557 respondents that
was comparable to the 2010 US Census population distribution, the
authors used multi-attribute utility regression and discrete choice

experiments to derive the QALYs associated with various PROMIS-29
health states. In a 2017 follow up to this work, the authors presented
an alternative model for mapping the PROMIS-29 to the EQ-5D 3L HUI
scores based on responses from 2623 individuals completing both in
struments. To account for the differences in scale, the authors trans
formed PROMIS-29 values to EQ-5D index scores using a transformation
function derived from linear, power function, polynomial and piecewise
linear regression models. After completing this conversion, the overall
correlation between PROMIS 29 and EQ-5D 3L utility weights was
0.783.37 A final method for conversion using linear and equipercentile
equating was presented by Thompson et al., in 2017. Using the PROMIS
Wave 1 sample and the Cleveland Clinic neurological disease patient
sample (n = 6906), the authors derived a series of models explaining
65–66% of the variance in actual EQ-5D index value, with differences of
0.01–0.02 between actual and predicted scores when stratified by age
group. Notably, the authors applied the Revicki et al., 2009 equation to
the dataset for direct comparison, and the updated equipercentile
equation outperformed on multiple dimensions including overall pre
dictive value, intraclass correlation coefficient and mean absolute
error.18 The authors did note the limitation of applying their model due
to its increased mathematical complexity.
Our results deviate slightly from those establishing the utility of
mapping the PROMIS GH instrument to EQ-5D HUI values. While these
larger studies quote mean differences of approximately .01–.02 between
actual and calculated values,17,18 our sample found HUI values that were
0.132 ± 0.084 points lower than the actual EQ-5D HUI on average, a
statistically significant difference. This result deviates significantly from
a subset of 4854 spine patients in the Thompson study. Using the initial
Revicki conversion equation, a difference of zero points was found be
tween the actual (0.61 ± 0.22) and calculated (0.61 ± 0.10) HUI
values.18
Despite the significant difference in absolute scores observed, the
PROMIS GH HUI did demonstrate positive association with the EQ-5D
HUI across various measures. The correlation coefficient in our sample
(r = 0.73, p < .001) was nearly identical to that of Revicki in the overall
PROMIS Wave 1 population (r = 0.785).18 In addition, the ICC of 0.857
(p < .001), superior to that of 0.73 in the Revicki model.17 Further
supporting the utility of the PROMIS GH HUI were the results of the
Bland Altman analysis which indicated strong agreement between the
instruments and no proportional bias. Finally, the strong reliability as
demonstrated by Cronbach’s alpha assessment of PROMIS GH domains
and with the overall scores provides further support for use of the
methodology.
A potential benefit to using converted PROMIS GH HUI scores is the
reduction of ceiling effects observed in EQ-5D HUI scores. While the
Revicki methodology has been critiqued for its inability to produced
high health state values, our results suggest the method has relatively
low ceiling effects at 3% compared to the 42% of patients who reported a
perfect health state using the EQ-5D. However, caution must be taken
when comparing results using the alternative methodologies, as studies
using the converted PROMIS GH converted HUI values will result in
lower absolute levels of health status that will decrease the overall costeffectiveness of interventions. Despite the limitations of the Revicki
methodology, we find its simple and transparent formula attractive, and
suggest it presents a low barrier for incorporation into standard clinical
practice if a composite HUI is desired by practitioners. Further, its ability
to use the PROMIS GH short form instrument rather than the 29-item
PROMIS-29 used by alternative conversion formulas enhances its abil
ity to be practically applied in time-constrained settings.
The primary limitation of our study is its small sample size. Given our
sample population of only 33 patients, it is unsurprising that our results
showed deviation from the normal distribution and previously pub
lished studies. Additionally, our study used paper forms of both the EQ5D 3L and PROMIS Global Health v1.2 instruments. This has the po
tential to limit the applicability of our findings to patients using web
based and alternative versions of these instruments such as the computer
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adapted test. Despite these limitations, we feel the study holds signifi
cant value as it is the first evaluation of the conversion of PROMIS Global
Health to EQ-5D health utility scores in this population to the authors’
knowledge.
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5. Conclusion
Conversion of the PROMIS Global Health to EQ-5D health utility
index value appears to be a viable option for evaluating the health status
of patients undergoing surgery for spinal stenosis in the presence of
lumbar degenerative spondylolisthesis. The convergent construct val
idity, reliability and coverage of the converted scores compare favorably
to those of the actual EQ-5D HUI. Further study of the conversion
methodology in a larger population of patients undergoing spine surgery
is recommended before conversion of PROMIS Global Health to EQ-5D
health utility index values is widely adopted for evaluation of health
status in this population.
Funding
No funding was received for this study.
Ethical approval
All procedures performed in studies involving human participants
were in accordance with the ethical standards of the institutional and/or
national research committee and with the 1964 Helsinki declaration and
its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants
included in the study.
Declaration of competing interest
All authors declare they have no conflicts of interest.
References
1 Sisko AM, Keehan SP, Poisal JA, et al. National health expenditure projections, 201827: economic and demographic trends drive spending and enrollment growth. Health
Aff. 2019;38(3):491–501. https://doi.org/10.1377/hlthaff.2018.05499.
2 Kalichman L, Kim DH, Li L, Guermazi A, Berkin V, Hunter DJ. Spondylolysis and
spondylolisthesis: prevalence and association with low back pain in the adult
community-based population. Spine. 2009;34(2):199–205. https://doi.org/10.1097/
BRS.0b013e31818edcfd.
3 Weiss AJ, Elixhauser A, Andrews RM. Statistical Brief #170: Characteristics of
Operating Room Procedures in U.S. Hospitals, 2011. In: Quality AfHRa, ed. 2014.
Rockville, MD.
4 Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for
lumbar degenerative spondylolisthesis. N Engl J Med. 2007;356(22):2257–2270.
https://doi.org/10.1056/NEJMoa070302.
5 Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical compared with nonoperative
treatment for lumbar degenerative spondylolisthesis. four-year results in the Spine
Patient Outcomes Research Trial (SPORT) randomized and observational cohorts.
J Bone Joint Surg. 2009;91(6):1295–1304. https://doi.org/10.2106/JBJS.H.00913.
6 Abdu WA, Sacks OA, Tosteson ANA, et al. Long-term results of surgery compared
with nonoperative treatment for lumbar degenerative spondylolisthesis in the spine
patient outcomes research trial (SPORT). Spine. 2018;43(23):1619–1630. https://
doi.org/10.1097/BRS.0000000000002682.
7 Kernick DP. Introduction to health economics for the medical practitioner. Postgrad
Med. 2003;79:147–150.
8 Fryback DG, Dunham NC, Palta M, et al. US norms for six generic health-related
quality-of-life indexes from the National Health Measurement study. Med Care. 2007;
45(12):1162–1170. https://doi.org/10.1097/MLR.0b013e31814848f1.
9 Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl
Health Econ Health Pol. 2017;15(2):127–137. https://doi.org/10.1007/s40258-0170310-5.

72

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on March 08, 2021.
For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

